Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Pricing your quoteWhy Your RFP Pricing Strategy Is Costing You
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More printing services and supplies bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›CHEMOTHERAPY AND YOU

US Government Publishing Office·United States of America

CHEMOTHERAPY AND YOU

Closes 12/5/2025$2k – $3kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The US Government Publishing Office is seeking a vendor to produce 300 booklets titled "CHEMOTHERAPY AND YOU". The booklets should be printed in four-color process with some type reversing out to appear white. The covers and text should be printed on gloss-coated paper, and the final output should be a minimum of 150-line screen and at a minimum resolution of 1200 x 1200 dpi x 1 bit or 600 x 600 dpi x 4-bit depth technology. The vendor should also provide digital color one-off proofs created using the same output device/RIP that will be used to produce the final printed product. The project requires a high level of quality, with attention to detail and adherence to the specified standards. Some key features of the project include: * 300 booklets with 56 text pages plus a separate wraparound cover * Four-color process printing with some type reversing out to appear white * Gloss-coated paper for covers and text * Minimum 150-line screen and 1200 x 1200 dpi x 1 bit or 600 x 600 dpi x 4-bit depth technology * Digital color one-off proofs * Saddle stitch binding in 2 places on the 10-7/8 / 11" inch side * Shrink wrap in 25's and pack suitably in cartons and shipping containers to ensure pamphlets are not damaged during shipment * Notification of shipment to the agency and delivery to the Southwest Region GPO

Attached files

Contact

Timothy Sankey(Contract Administrator)

[email protected]

(202) 512-0488

Key dates

Opened
12/4/2025
Closes
12/5/2025

Last updated

Details

Type
Request for Quotation
Industry
Printing Services and Supplies
NAICS
323111
Solicitation №
JACKET:470-138

Budget estimate

$1,500 – $3,000

The budget for this opportunity can be estimated based on the quantity of booklets to be produced and the complexity of the printing and binding process. Assuming an average cost of $5-10 per booklet for high-quality printing and binding, the total budget can be estimated to be around $1,500-$3,000. However, this is a rough estimate and the actual budget may vary depending on the vendor's pricing and the specific requirements of the project. Factors that may influence the likely payment range include the cost of materials, labor, and equipment, as well as the vendor's profit margin.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 60%

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 1/24/2027Opened 3/10/2026

U.S. National Institutes of Health·United States of America

59% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

U.S. National Institutes of Health·United States of America

59% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

59% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025

U.S. National Institutes of Health·United States of America

59% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

59% match

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Closes 1/25/2027Opened 8/28/2025

U.S. National Institutes of Health·United States of America

58% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

58% match

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Closes 10/19/2027Opened 7/2/2025

U.S. National Institutes of Health·United States of America

58% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

58% match

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

58% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

58% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

58% match

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Closes 1/24/2027Opened 6/2/2026

U.S. National Institutes of Health·United States of America

57% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

Mississippi Department of Health·Mississippi

57% match

Cancer Survivorship Evaluation

Closes 11/2/2026Opened 10/13/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

57% match

Promoting Cancer Surveillance Workforce, Education, and Data Use

Closes 4/6/2027Opened 9/28/2026

U.S. National Institutes of Health·United States of America

57% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

57% match

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028Opened 11/12/2024

U.S. National Institutes of Health·United States of America

57% match

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

57% match

Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

Closes 11/10/2026Opened 3/3/2026

U.S. National Institutes of Health·United States of America

57% match

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

Closes 11/22/2028Opened 6/16/2025

U.S. National Institutes of Health·United States of America

57% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Centers for Disease Control - NCCDPHP·United States of America

57% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 2/5/2027Opened 9/3/2026

U.S. Food and Drug Administration·United States of America

57% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

U.S. National Institutes of Health·United States of America

56% match

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/18/2026